Asking the Right Questions in IDG: A Physician’s Framework for Hospice Recertification That Stands Up to CMS Audit

One of the most important responsibilities of the hospice physician is determining whether a patient continues to meet Medicare hospice eligibility at recertification. While reviewing the medical record is essential, the Interdisciplinary Group (IDG) meeting provides something equally valuable: the opportunity to synthesize the lived clinical experience of the entire care team into a clear understanding of the patient’s trajectory.

Too often, recertification discussions become a checklist of diagnoses or medication changes. While these details matter, they rarely answer the question that Medicare is truly asking:

Has this patient demonstrated continued decline consistent with a prognosis of six months or less if the terminal illness follows its expected course?

The physician’s role is not simply to verify that the patient remains ill. Rather, it is to determine whether the patient has experienced progressive decline, increasing symptom burden, and ongoing functional deterioration that support continued hospice eligibility. The most effective way to accomplish this is by asking thoughtful, open-ended questions that encourage nurses and the interdisciplinary team to describe the patient’s trajectory—not simply report isolated facts.

The following framework has become my preferred approach during IDG. It is designed to encourage clinical reasoning, promote meaningful discussion, and generate documentation that accurately reflects the patient’s decline while supporting compliance with Medicare and CMS Local Coverage Determinations (LCDs).

Why Your Questions Matter

CMS does not expect the physician’s recertification narrative to be a copy of the nursing note. In fact, CMS specifically instructs that the physician must synthesize the available clinical information and explain why those findings support a terminal prognosis.

That synthesis begins during IDG.

Well-crafted questions help uncover subtle but clinically meaningful changes that may otherwise go undocumented. They encourage nurses to compare the patient’s current condition with previous benefit periods, identify trends over time, and articulate the significance of those changes. These conversations not only strengthen documentation but also improve interdisciplinary understanding of disease progression and goals of care.

Rather than asking, “How is the patient doing?” consider asking, “What has changed since the last benefit period?” The difference is profound. One invites a status update; the other requires an assessment of decline.

1. Start with the Big Picture

Every recertification discussion should begin by exploring overall disease progression.

Some of my favorite opening questions include:

• Compared with the previous benefit period, what has changed?
• What evidence tells you this patient is closer to the end of life today than they were sixty or ninety days ago?
• What has declined the most?
• What concerns you most about this patient?
• If CMS audited this chart tomorrow, what would you highlight as evidence of ongoing decline?

These broad questions frequently reveal the most compelling clinical information before diving into individual body systems.

2. Explore Functional Decline

Function remains one of the strongest predictors of prognosis across nearly every terminal diagnosis.

Rather than asking whether the patient is still ambulatory, ask how their function has changed.

Consider exploring:

• Has the PPS declined?
• Is the patient spending more hours in bed?
• How many hours each day are they sleeping?
• Have they progressed from walking independently to requiring a walker, wheelchair, or becoming bedbound?
• Have transfers become more difficult?
• Are they losing trunk control?
• Can they still reposition themselves?
• Have they become dependent in additional activities of daily living?
• Are falls becoming more frequent?
• Can they still feed themselves?

Remember that Medicare is interested in trajectories, not isolated observations. A patient who progresses from requiring minimal assistance to complete dependence over several benefit periods demonstrates meaningful decline.

3. Assess Nutritional Status

Progressive nutritional decline is among the most powerful indicators of terminal disease progression.

During IDG, explore far more than weight alone.

Ask about:

• Appetite changes
• Percentage of meals consumed
• Whether intake consists primarily of bites or sips
• Fluid intake
• Dysphagia
• Pocketing food
• Choking episodes
• Coughing during meals
• Weight loss
• Mid-arm circumference trends
• Muscle wasting
• Temporal wasting
• Sarcopenia
• Cachexia

Sometimes the most revealing answer is simply, “The family says she just doesn’t enjoy eating anymore.”

That statement often reflects advanced disease rather than poor dietary choices.

4. Evaluate Cognitive Decline

For patients with dementia or neurologic disease, cognitive changes frequently drive prognosis.

Ask nurses to compare cognition over time.

Questions may include:

• Is the patient less interactive?
• Are they recognizing family members less often?
• Have they become less verbal?
• Are they sleeping more?
• Can they still communicate needs?
• Has agitation increased?
• Are hallucinations becoming more frequent?
• Has the FAST stage progressed?
• Has communication become limited to only a few intelligible words?

These subtle changes often represent significant neurologic progression.

5. Examine Symptom Burden

Hospice exists to relieve suffering. Increasing symptom burden frequently reflects advancing disease.

Ask about:

• Pain
• Dyspnea
• Oxygen requirements
• Anxiety
• Fatigue
• Weakness
• Restlessness
• Secretions
• Edema
• Nausea
• Pressure injuries
• Skin integrity
• Sleep disruption

Then ask an important follow-up question:

“Are symptom management needs increasing?”

Increasing medication requirements, more frequent nursing visits, or escalating caregiver education often indicate advancing illness even when vital signs remain relatively stable.

6. Tailor the Discussion to the Disease

Every terminal diagnosis progresses differently.

Heart failure patients may develop worsening edema, orthopnea, declining exercise tolerance, increasing oxygen requirements, and repeated episodes of decompensation.

Patients with COPD may become dyspneic while speaking, require continuous oxygen, experience recurrent exacerbations, or lose weight because eating itself becomes exhausting.

Patients living with dementia often demonstrate progressive dysphagia, recurrent aspiration, increasing dependence, contractures, incontinence, and loss of meaningful verbal communication.

Cancer patients may exhibit progressive cachexia, worsening pain, increasing opioid requirements, declining performance status, and cessation of disease-directed therapy.

Stroke survivors may experience recurrent aspiration, worsening dysphagia, increasing immobility, and further neurologic decline.

Keeping disease-specific trajectories in mind allows the physician to recognize clinically meaningful progression rather than relying on diagnosis alone.

7. Identify Medical Complications

Complications often tell the story of disease progression better than diagnoses.

Ask whether the patient has experienced:

• Falls
• Fractures
• Emergency department visits
• Hospitalizations
• Aspiration pneumonia
• Urinary tract infections
• Sepsis
• Pressure ulcers
• Skin tears
• Recurrent cellulitis
• Worsening wounds

These events demonstrate increasing frailty and physiologic vulnerability.

8. Never Forget the Caregiver

Families frequently notice decline before objective measurements change.

Ask nurses:

• What is the caregiver telling you?
• Has caregiving become significantly more difficult?
• What new assistance is now required?
• Are family members expressing concern that the patient is “not the same person”?
• Have visits increased because the family needs more support?

Increasing caregiver burden often mirrors increasing patient dependence and symptom complexity.

My Two Favorite Questions

If I could ask only two questions during every recertification discussion, they would be these.

“What objective evidence of decline have you documented since the last certification period?”

This question immediately focuses the discussion on measurable clinical progression rather than subjective impressions.

My second question is even more powerful.

“If this patient were discharged from hospice today, what would concern you the most?”

The answers frequently include:

• uncontrolled dyspnea
• progressive weakness
• inability to eat
• recurrent aspiration
• uncontrolled pain
• increasing confusion
• caregiver exhaustion
• inability to safely remain at home

Those responses often summarize exactly why hospice remains appropriate.

The CMS Perspective

Physicians sometimes worry that they must prove a patient is actively dying.

That is not the standard.

The Medicare hospice benefit requires documentation supporting a prognosis of six months or less if the disease follows its expected course. Many eligible patients experience gradual decline over months rather than dramatic deterioration over days. Your role is to demonstrate that the patient’s overall clinical trajectory remains consistent with advanced, progressive, life-limiting illness.

Objective trends over time are far more persuasive than any single abnormal finding. Declining PPS, increasing dependence in activities of daily living, progressive dysphagia, worsening nutritional status, recurrent infections, escalating symptom burden, and increasing caregiver needs collectively paint a compelling picture of terminal disease progression.

Bringing It All Together

A structured recertification discussion does more than satisfy regulatory requirements. It improves communication among the interdisciplinary team, sharpens clinical reasoning, and ensures that every patient’s story is accurately reflected in the medical record.

When physicians consistently ask thoughtful, comparative questions, IDG evolves from a routine meeting into a meaningful clinical conference. Nurses become more attuned to documenting trajectories rather than isolated events. Physician narratives become richer, more individualized, and easier to defend during audit. Most importantly, patients continue to receive hospice services based on a clear, evidence-based understanding of their ongoing decline.

The best recertification conversations are not about proving that someone is dying. They are about recognizing, documenting, and honoring the progression of serious illness while ensuring that patients continue to receive the compassionate, expert care they need during the final chapter of life.

The next time you lead IDG, begin with one simple question:

“What has changed since the last benefit period?”

You may be surprised how often the answer contains everything you need to determine continued hospice eligibility.

The framework presented in this article is informed by current CMS hospice regulations, Medicare Local Coverage Determinations, validated prognostic instruments including the Palliative Performance Scale (PPS), Karnofsky Performance Status (KPS), and Functional Assessment Staging (FAST), as well as the broader peer-reviewed literature on prognostication, frailty, advanced illness trajectories, and interdisciplinary hospice care. While no checklist replaces physician judgment, thoughtful synthesis of longitudinal clinical decline remains the cornerstone of accurate hospice recertification and high-quality end-of-life care.

REFERENCES:

Centers for Medicare & Medicaid Services (CMS). Medicare Benefit Policy Manual, Chapter 9 – Coverage of Hospice Services.

CMS Local Coverage Determination (LCD): Hospice – Determining Terminal Status (L34538).

CMS Medicare Learning Network. Hospice Services: Provider Compliance Tips.

Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996 Spring;12(1):5-11.

Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, Volicer L, Givens JL, Hamel MB. The clinical course of advanced dementia. N Engl J Med. 2009 Oct 15;361(16):1529-38.

Medical guidelines for determining prognosis in selected non-cancer diseases. The National Hospice Organization. Hosp J. 1996;11(2):47-63.

Schonwetter RS, Han B, Small BJ, Martin B, Tope K, Haley WE. Predictors of six-month survival among patients with dementia: an evaluation of hospice Medicare guidelines. Am J Hosp Palliat Care. 2003 Mar-Apr;20(2):105-13.